These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 19061770)
1. Radiotherapy followed by adjuvant temozolomide treatment of malignant glioma. Yang TM; Wang HC; Lin YJ; Lin WC; Lu CH; Chang WN; Chang HW; Ho JT Surg Neurol; 2008 Dec; 70 Suppl 1():S1:60-3. PubMed ID: 19061770 [TBL] [Abstract][Full Text] [Related]
2. Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide. Yaman E; Buyukberber S; Benekli M; Oner Y; Coskun U; Akmansu M; Ozturk B; Kaya AO; Uncu D; Yildiz R Clin Neurol Neurosurg; 2010 Oct; 112(8):662-7. PubMed ID: 20627551 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of 3-dimensional conformal radiotherapy combined with temozolomide for glioma]. Wang L; Tu Q; Zhou W; Zhou R Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1106-10. PubMed ID: 22169729 [TBL] [Abstract][Full Text] [Related]
4. High-grade gliomas: results in patients treated with adjuvant radiotherapy alone and with adjuvant radio-chemotherapy. Valeriani M; Ferretti A; Franzese P; Tombolini V Anticancer Res; 2006; 26(3B):2429-35. PubMed ID: 16821628 [TBL] [Abstract][Full Text] [Related]
6. Temozolomide and radiotherapy as first-line treatment of high-grade gliomas. Corsa P; Parisi S; Raguso A; Troiano M; Perrone A; Cossa S; Munafò T; Piombino M; Spagnoletti G; Borgia F Tumori; 2006; 92(4):299-305. PubMed ID: 17036520 [TBL] [Abstract][Full Text] [Related]
7. Long-term use of temozolomide: could you use temozolomide safely for life in gliomas? Khasraw M; Bell D; Wheeler H J Clin Neurosci; 2009 Jun; 16(6):854-5. PubMed ID: 19303779 [TBL] [Abstract][Full Text] [Related]
8. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110 [TBL] [Abstract][Full Text] [Related]
9. Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy. Charnley N; West CM; Barnett CM; Brock C; Bydder GM; Glaser M; Newlands ES; Swindell R; Matthews J; Price P Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):331-8. PubMed ID: 16839701 [TBL] [Abstract][Full Text] [Related]
10. Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role? Wen PY J Clin Oncol; 2010 Apr; 28(12):1977-9. PubMed ID: 20308652 [No Abstract] [Full Text] [Related]
11. Temozolomide in paediatric high-grade glioma: a key for combination therapy? Verschuur AC; Grill J; Lelouch-Tubiana A; Couanet D; Kalifa C; Vassal G Br J Cancer; 2004 Aug; 91(3):425-9. PubMed ID: 15266331 [TBL] [Abstract][Full Text] [Related]
12. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843 [TBL] [Abstract][Full Text] [Related]
13. Combined radiotherapy and temozolomide in patients with recurrent high grade glioma. Schönekaes K; Mücke R; Panke J; Rama B; Wagner W Tumori; 2002; 88(1):28-31. PubMed ID: 12004846 [TBL] [Abstract][Full Text] [Related]
14. Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatment. Yaman E; Buyukberber S; Uner A; Coskun U; Akmansu M; Benekli M; Yamac D; Ozturk B; Kaya AO; Yildiz R; Ozkan S; Gunel N Onkologie; 2008 Jun; 31(6):309-13. PubMed ID: 18547971 [TBL] [Abstract][Full Text] [Related]
15. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Brandsma D; Stalpers L; Taal W; Sminia P; van den Bent MJ Lancet Oncol; 2008 May; 9(5):453-61. PubMed ID: 18452856 [TBL] [Abstract][Full Text] [Related]
16. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas. Chamberlain MC Expert Rev Neurother; 2010 Oct; 10(10):1537-44. PubMed ID: 20925470 [TBL] [Abstract][Full Text] [Related]
17. Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma. Yang P; Zhang C; Cai J; You G; Wang Y; Qiu X; Li S; Wu C; Yao K; Li W; Peng X; Zhang W; Jiang T Oncotarget; 2016 Nov; 7(48):80091-80100. PubMed ID: 27590514 [TBL] [Abstract][Full Text] [Related]
18. Temozolomide chemotherapy in patients with recurrent malignant gliomas. Yang SH; Kim MK; Lee TK; Lee KS; Jeun SS; Park CK; Kang JK; Kim MC; Hong YK J Korean Med Sci; 2006 Aug; 21(4):739-44. PubMed ID: 16891823 [TBL] [Abstract][Full Text] [Related]
19. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Stupp R; Hegi ME; Mason WP; van den Bent MJ; Taphoorn MJ; Janzer RC; Ludwin SK; Allgeier A; Fisher B; Belanger K; Hau P; Brandes AA; Gijtenbeek J; Marosi C; Vecht CJ; Mokhtari K; Wesseling P; Villa S; Eisenhauer E; Gorlia T; Weller M; Lacombe D; Cairncross JG; Mirimanoff RO; ; Lancet Oncol; 2009 May; 10(5):459-66. PubMed ID: 19269895 [TBL] [Abstract][Full Text] [Related]
20. Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas. Minniti G; Scaringi C; De Sanctis V; Lanzetta G; Falco T; Di Stefano D; Esposito V; Enrici RM J Neurooncol; 2013 Jan; 111(2):187-94. PubMed ID: 23129347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]